Differential dropout may affect exacerbation risk estimates differently in moderate-to-very severe COPD

P. Calverley, G. Eriksson, D. Postma, C. Jenkins, A. Anzueto, B. Make, A. Persson, M. Fagerås, T. Similowski (Liverpool, United Kingdom; Lund, Mölndal, Sweden; Groningen, Netherlands; Camperdown, Australia; San Antonio, Denver, United States Of America; Paris, France)

Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights
Session: Trials in COPD: novel treatments and insights
Session type: Poster Discussion
Number: 2877
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Calverley, G. Eriksson, D. Postma, C. Jenkins, A. Anzueto, B. Make, A. Persson, M. Fagerås, T. Similowski (Liverpool, United Kingdom; Lund, Mölndal, Sweden; Groningen, Netherlands; Camperdown, Australia; San Antonio, Denver, United States Of America; Paris, France). Differential dropout may affect exacerbation risk estimates differently in moderate-to-very severe COPD. Eur Respir J 2012; 40: Suppl. 56, 2877

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of severe exacerbations in patients with moderate and severe asthma
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018



Impact of moderate and severe exacerbations in severe COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Are COPD exacerbations associated with the severity of the disease?
Source: Eur Respir J 2005; 26: Suppl. 49, 300s
Year: 2005

Early occurrence of any COPD exacerbation predicts further higher risk of moderate/severe exacerbations regardless of recording tool: the FLAME study
Source: International Congress 2017 – Management of COPD
Year: 2017


What are the differences between moderate and severe COPD exacerbation groups?
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017

Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021



Markers of T2-inflammation in patients with severe asthma and concomitant COPD
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

COPD mortality after severe exacerbations
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020


In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021



Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005


Predictors of severe COVID-19 in COPD
Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies
Year: 2021



β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011

Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 72s
Year: 2007

Genetic comparison between severe persistent asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 81s
Year: 2003